Skip to content
Medical Health Aged Care

Bupa tops-up cashback to $395 million

26 September, 2023 2 mins read

Bupa has today announced a cashback top-up of $75 million, taking the amount that will be returned to eligible members to $395 million, with many receiving it ahead of Christmas.

 

The $395 million total cashback includes the extra $75 million announced today, and Bupa’s cashback of $320 million committed to in June this year.

 

Bupa will begin paying the cashback in November, with Bupa’s 1.8 million eligible policyholders to receive between $47 and $344, depending on their policy.

 

Bupa Health Insurance Managing Director Chris Carroll said members would receive the money at a time of year when household expenditure usually increased, especially against the backdrop of high inflationary pressures.

 

“We’re topping up our members’ cashback to a total of $395 million which we hope will support them through the current cost of living challenges, and with their health and wellbeing,” he said.

 

“The money will go directly into our members’ bank accounts, giving them more choice to use the money in a way that is most valuable to them.”

 

Bupa’s total announced financial support to customers since the pandemic started is $1.35 billion through cashbacks, premium deferrals, financial assistance for impacted customers and other support programs.

 

The cashback is part of Bupa’s cost of living support and COVID-19 related savings.

 

This latest cashback will be available to all domestic Australian resident policyholders who had domestic private health cover with Bupa for a minimum of three months between 1 July 2022 and 30 June 2023.

 

Mr Carroll said all members needed to do was check their bank details were up to date.

 

“The money will be paid using the same bank details from the previous cashbacks, so I encourage our members to make sure their details are up to date with us,” he said.


For further details about the cashback, please click here

 

How Bupa has supported customers since the pandemic

 

Total announced commitments are $1.35 billion comprised of:

$75 million cashback announced today

$320 million cashback announced in June 2023

$154 million six-month freeze on 2023 premiums. 

$315 million cashback announced in September 2022.

$168 million through a seven-month premium delay for all members in 2022.

$120 million cashback announced September 2021.

$134 million six-month premium freeze announced in March 2020.

$58 million financial hardship package from 2020.

$5 million mental health support package from 2020.

 

 

ENDS

 

 

For more information, please contact:
Aleks Devic                                                    
Senior External Communications Manager, Bupa                                    
Email:
aleks.devic@bupa.com.au     

Mob: 0412 868 933                                                      

 

 

About Bupa Asia Pacific

Bupa is an international healthcare group which has been committed to a purpose of helping people live longer, healthier, happier lives and making a better world for more than 70 years.

Bupa Asia Pacific operates in Australia, New Zealand and Hong Kong, supporting about 6.5 million customers through a broad range of health and care services including health insurance, aged care, dental, medical, optical and hearing services.

Employing more than 20,000 people in the region, we believe that we can make a real difference to the lives of customers through our values, purpose and the way that we deliver personalised care.

Since 2002, we have reinvested approximately $6 billion in the region, with the Bupa Foundation investing more than $34 million to support 130+ health and care projects.

 

 

More from this category

  • Medical Health Aged Care, Research Development
  • 06/09/2024
  • 15:19
La Trobe University

Breakthrough in the hunt for broad-spectrum malaria therapy

Scientists at La Trobe University have discovered a new antibody-like molecule which could be used in therapy to prevent infection from multiple malaria parasite species. The research, recently published in Nature Communications, found that when the molecule WD34 binds with a protein produced by malaria parasites, it inhibits their ability to infect cells at different stages of the disease. Led by Professor Michael Foley, Professor Robin Anders and PhD candidate Dimuthu Angage at the La Trobe Institute for Molecular Science (LIMS), the research also showed that WD34 can protect against several different malaria parasite species. Professor Foley said the discovery…

  • Medical Health Aged Care
  • 06/09/2024
  • 10:16
Royal Australian College of GPs

NSW Government’s expanded role for pharmacy is reckless and unsafe for patients: RACGP

The New South Wales Government’s move to expand the scope of pharmacists to treat a range of conditions is politically driven and risks the health of people across the state, says the Royal Australian College of GPs. Health Minister Ryan Park made the announcement at a Pharmacy Guild conference last night that work was underway to expand pharmacists' scope to treat ear infections, wound management, nausea, gastro-oesophageal reflux disease, acne, and muscle and joint pain. RACGP NSW Chair Dr Rebekah Hoffman slammed the move as reckless and putting politics before patient safety. “This is politically driven policy, and it has…

  • CharitiesAidWelfare, Medical Health Aged Care
  • 06/09/2024
  • 05:00
Lloyds Auctioneers and Valuers

Bid for a Cause: Whisky Auction Supports Brain Cancer Fight

After Jack was diagnosed with Glioblastoma Multiforme (GBM), one of the most aggressive and deadly brain cancers, he was given just 12 months to…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.